Track topics on Twitter Track topics that are important to you
Illumina (NASDAQ: ILMN) has appointed Phil Febbo to serve as chief medical officer of the San Diego genomics technologies company. Febbo most recently worked as chief medical officer of Redwood City, CA-based Genomic Health (NASDAQ: GHDX). Before that, he was a professor of medicine and urology at the University of California, San Francisco.
Original Article: Illumina Picks Genomic Health’s Phil Febbo for Chief Medical OfficerNEXT ARTICLE
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...